IVD Medical Holding Limited

SEHK:1931 Stock Report

Market Cap: HK$3.1b

IVD Medical Holding Management

Management criteria checks 3/4

IVD Medical Holding's CEO is Kuk Sing Ho, appointed in Jun 2019, has a tenure of 4.83 years. total yearly compensation is CN¥3.70M, comprised of 99.8% salary and 0.2% bonuses, including company stock and options. directly owns 12.96% of the company’s shares, worth HK$398.42M. The average tenure of the management team and the board of directors is 4.8 years and 2.5 years respectively.

Key information

Kuk Sing Ho

Chief executive officer

CN¥3.7m

Total compensation

CEO salary percentage99.8%
CEO tenure4.8yrs
CEO ownership13.0%
Management average tenure4.8yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 25
IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 03
IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings

Mar 30
IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings

IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year

Mar 20
IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year

If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity

Mar 06
If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Feb 08
IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Oct 22
Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)

IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher

Oct 01
IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297

Aug 22
IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 05
IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556

Mar 22
IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556

Returns At IVD Medical Holding (HKG:1931) Are On The Way Up

Feb 16
Returns At IVD Medical Holding (HKG:1931) Are On The Way Up

Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?

Oct 16
Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?

Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)

Sep 28
Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)

IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

May 16
IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

Apr 14
IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 23
IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Mar 16
IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital

Jul 30
IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well

May 04
These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well

There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital

Apr 20
There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital

IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year

Mar 05
IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year

Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 15
Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?

Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like

Jan 31
Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like

A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Jan 16
A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?

Jan 01
Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?

How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?

Dec 17
How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?

Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?

Dec 02
Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?

IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.

Nov 19
IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.

CEO Compensation Analysis

How has Kuk Sing Ho's remuneration changed compared to IVD Medical Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023CN¥4mCN¥4m

CN¥238m

Sep 30 2023n/an/a

CN¥235m

Jun 30 2023n/an/a

CN¥232m

Mar 31 2023n/an/a

CN¥221m

Dec 31 2022CN¥5mCN¥4m

CN¥210m

Sep 30 2022n/an/a

CN¥193m

Jun 30 2022n/an/a

CN¥177m

Mar 31 2022n/an/a

CN¥176m

Dec 31 2021CN¥4mCN¥4m

CN¥175m

Compensation vs Market: Kuk Sing's total compensation ($USD510.59K) is about average for companies of similar size in the Hong Kong market ($USD394.17K).

Compensation vs Earnings: Kuk Sing's compensation has been consistent with company performance over the past year.


CEO

Kuk Sing Ho (63 yo)

4.8yrs

Tenure

CN¥3,700,000

Compensation

Mr. Ho Kuk Sing serves as Executive Director, Chairman of the Board and Chief Executive Officer at IVD Medical Holding Limited since June 21, 2019. He was Director of IVD Medical Holding Limited since May...


Leadership Team

NamePositionTenureCompensationOwnership
Kuk Sing Ho
Chairman & CEO4.8yrsCN¥3.70m12.96%
CN¥ 398.4m
Xianya Lin
GM & Executive Director4.8yrsCN¥2.16m8.32%
CN¥ 255.7m
Kim Fai Law
CFO, Joint Company Secretary & Executive Directorless than a yearno datano data
Siu Kei Ken Chan
Executive Directorless than a yearno datano data
Bo Yang
Financial Controller8.2yrsno datano data
Wai Yan Lam
Company Secretaryno datano datano data

4.8yrs

Average Tenure

46yo

Average Age

Experienced Management: 1931's management team is considered experienced (4.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kuk Sing Ho
Chairman & CEO7.9yrsCN¥3.70m12.96%
CN¥ 398.4m
Xianya Lin
GM & Executive Director8.3yrsCN¥2.16m8.32%
CN¥ 255.7m
Kim Fai Law
CFO, Joint Company Secretary & Executive Directorless than a yearno datano data
Siu Kei Ken Chan
Executive Directorless than a yearno datano data
Sze Lok Wong
Independent Non-Executive Directorless than a yearno datano data
Renqian Zhong
Independent Non-Executive Director4.8yrsCN¥120.00kno data
Ka Sing Leung
Independent Non-Executive Director4.8yrsCN¥120.00kno data
Haiyun Yao
Non-Executive Director2.5yrsno datano data
Fei Liu
Non-executive Directorless than a yearno datano data

2.5yrs

Average Tenure

50yo

Average Age

Experienced Board: 1931's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.